Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic
Patients with COVID-19 may develop various neurological disorders of the central and peripheral nervous systems. It is known that diabetes mellitus (DM) type 1 or 2, cardiovascular diseases, obesity, old age and old age, male gender are risk factors for a severe course and complications of COVID-19....
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2021-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/6541 |
| _version_ | 1797841722400571392 |
|---|---|
| author | V. A. Golovacheva A. A. Golovacheva |
| author_facet | V. A. Golovacheva A. A. Golovacheva |
| author_sort | V. A. Golovacheva |
| collection | DOAJ |
| description | Patients with COVID-19 may develop various neurological disorders of the central and peripheral nervous systems. It is known that diabetes mellitus (DM) type 1 or 2, cardiovascular diseases, obesity, old age and old age, male gender are risk factors for a severe course and complications of COVID-19. Currently, the COVID-19 pandemic is ongoing, and patients with the listed risk factors are recommended to follow a regime of social restriction or self-isolation. Outpatient treatment is most appropriate for this category of patients. Patients with diabetes who have undergone COVID-19 are at risk of developing or progressing diabetic polyneuropathy (DPN). It seems relevant to develop the principles of effective treatment of patients with DM and DPN in outpatient settings. Glycemic level correction, diet, weight normalization, therapy of combined cardiovascular diseases, an increase of physical activity, sleep normalization, maintenance of normal psychological state are the main principles of treatment of patients with DM and DPN in COVID-19 pandemic conditions. Pathogenetic therapy of DPN continues to be discussed, in our country the preparations of B vitamins, alpha-lipoic acid are widely used. B-group vitamin preparations can be used in the form of tablets or solutions for intramuscular injections. The effectiveness of B vitamins (B1, B6, B12) in the treatment of a severe course of COVID- 19, prevention of complications of COVID-19, especially in elderly patients and with diabetes is discussed. |
| first_indexed | 2024-04-09T16:36:26Z |
| format | Article |
| id | doaj.art-c8f1109394a441d39dfe28272ca4137a |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:36:26Z |
| publishDate | 2021-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-c8f1109394a441d39dfe28272ca4137a2023-04-23T06:56:53ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902021-12-0101912613310.21518/2079-701X-2021-19-126-1335904Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 PandemicV. A. Golovacheva0A. A. Golovacheva1Sechenov First Moscow State Medical University (Sechenov University)Sechenov First Moscow State Medical University (Sechenov University)Patients with COVID-19 may develop various neurological disorders of the central and peripheral nervous systems. It is known that diabetes mellitus (DM) type 1 or 2, cardiovascular diseases, obesity, old age and old age, male gender are risk factors for a severe course and complications of COVID-19. Currently, the COVID-19 pandemic is ongoing, and patients with the listed risk factors are recommended to follow a regime of social restriction or self-isolation. Outpatient treatment is most appropriate for this category of patients. Patients with diabetes who have undergone COVID-19 are at risk of developing or progressing diabetic polyneuropathy (DPN). It seems relevant to develop the principles of effective treatment of patients with DM and DPN in outpatient settings. Glycemic level correction, diet, weight normalization, therapy of combined cardiovascular diseases, an increase of physical activity, sleep normalization, maintenance of normal psychological state are the main principles of treatment of patients with DM and DPN in COVID-19 pandemic conditions. Pathogenetic therapy of DPN continues to be discussed, in our country the preparations of B vitamins, alpha-lipoic acid are widely used. B-group vitamin preparations can be used in the form of tablets or solutions for intramuscular injections. The effectiveness of B vitamins (B1, B6, B12) in the treatment of a severe course of COVID- 19, prevention of complications of COVID-19, especially in elderly patients and with diabetes is discussed.https://www.med-sovet.pro/jour/article/view/6541diabetes mellitusdiabetic polyneuropathytreatmentb vitaminsthiaminepyridoxinecyanocobalamincovid-19 |
| spellingShingle | V. A. Golovacheva A. A. Golovacheva Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic Медицинский совет diabetes mellitus diabetic polyneuropathy treatment b vitamins thiamine pyridoxine cyanocobalamin covid-19 |
| title | Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic |
| title_full | Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic |
| title_fullStr | Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic |
| title_full_unstemmed | Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic |
| title_short | Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic |
| title_sort | principles of treatment of patients with diabetic polyneuropathy in the covid 19 pandemic |
| topic | diabetes mellitus diabetic polyneuropathy treatment b vitamins thiamine pyridoxine cyanocobalamin covid-19 |
| url | https://www.med-sovet.pro/jour/article/view/6541 |
| work_keys_str_mv | AT vagolovacheva principlesoftreatmentofpatientswithdiabeticpolyneuropathyinthecovid19pandemic AT aagolovacheva principlesoftreatmentofpatientswithdiabeticpolyneuropathyinthecovid19pandemic |